WINT Windtree Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: WINT

Price (delayed)

$4.94

Market cap

$2.52M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$94.32

Enterprise value

-$118,716

Windtree Therapeutics, Inc. is advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders to treat patients in moments of crisis. Using new clinical approaches, Windtree is developing a multi-asset ...

Highlights
WINT's EPS has surged by 92% year-on-year and by 73% since the previous quarter
The company's net income rose by 48% YoY and by 18% QoQ
The equity has dropped by 66% year-on-year and by 55% since the previous quarter
Windtree Therapeutics's quick ratio has shrunk by 56% YoY and by 45% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://windtreetx.com
Peers: NWBO

Key stats

What are the main financial stats of WINT
Market
Shares outstanding
510,179
Market cap
$2.52M
Enterprise value
-$118,716
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.42
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$20.24M
EBITDA
-$19.75M
Free cash flow
-$13.45M
Per share
EPS
-$94.32
Free cash flow per share
-$62.47
Book value per share
$11.86
Revenue per share
$0
TBVPS
$33.23
Balance sheet
Total assets
$32.41M
Total liabilities
$29.02M
Debt
$1.83M
Equity
$3.39M
Working capital
$1.38M
Liquidity
Debt to equity
0.54
Current ratio
1.35
Quick ratio
1.12
Net debt/EBITDA
0.13
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-56.3%
Return on equity
-275.1%
Return on invested capital
-1,195.6%
Return on capital employed
-71.2%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

WINT stock price

How has the Windtree Therapeutics stock price performed over time
Intraday
16.24%
1 week
-5.54%
1 month
1,200%
1 year
208.75%
YTD
586.11%
QTD
1,311.43%

Financial performance

How have Windtree Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$20.6M
Net income
-$20.29M
Gross margin
N/A
Net margin
N/A
The operating income has soared by 50% YoY and by 22% from the previous quarter
The company's net income rose by 48% YoY and by 18% QoQ

Growth

What is Windtree Therapeutics's growth rate over time

Valuation

What is Windtree Therapeutics stock price valuation
P/E
N/A
P/B
0.42
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
WINT's EPS has surged by 92% year-on-year and by 73% since the previous quarter
The equity has dropped by 66% year-on-year and by 55% since the previous quarter
The price to book (P/B) is 62% less than the 5-year quarterly average of 1.1 and 40% less than the last 4 quarters average of 0.7

Efficiency

How efficient is Windtree Therapeutics business performance
The company's return on equity fell by 43% YoY
The ROIC has increased by 32% YoY but it has decreased by 7% from the previous quarter
The return on assets is up by 26% year-on-year and by 15% since the previous quarter

Dividends

What is WINT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for WINT.

Financial health

How did Windtree Therapeutics financials performed over time
The company's total assets is 12% higher than its total liabilities
Windtree Therapeutics's quick ratio has shrunk by 56% YoY and by 45% QoQ
The current ratio has dropped by 55% year-on-year and by 44% since the previous quarter
WINT's debt is 46% lower than its equity
The company's debt to equity has surged by 135% YoY and by 86% QoQ
The equity has dropped by 66% year-on-year and by 55% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.